Approval · Notice of Compliance 3924 · 1997
EOLARIX: Notice of Compliance 3924
Issued August 28, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3924
- Date
- August 28, 1997
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EOLARIX | 02211009 | — |
Medicinal ingredients
- MEASLES VIRUS VACCINE LIVE ATTENUATED 1 DOSE per VIAL
- RUBELLA VIRUS VACCINE 1 DOSE per VIAL